EXTENDED LOCAL RELEASE OF ANTIBODIES

The present disclosure provides compositions and methods for extended release of certain types of antibodies in vivo. It was discovered that such antibodies are able to initiate reversible gelation of hyaluronic acid (HA) by creating a depot that dissociates over time to release the antibody without...

Full description

Saved in:
Bibliographic Details
Main Authors HSU, Chung-Chiang, ALANI, Laman
Format Patent
LanguageEnglish
French
German
Published 08.11.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present disclosure provides compositions and methods for extended release of certain types of antibodies in vivo. It was discovered that such antibodies are able to initiate reversible gelation of hyaluronic acid (HA) by creating a depot that dissociates over time to release the antibody without any impact on its physical and chemical properties as well as its biological activity. As certain tissues and organs, such as eyes, joints and skins, contain HA, local injection of the antibodies to these tissues or organs will result in embedding of the antibody in gel formed from the HA, which becomes a repository of slow-released antibodies. In addition, slow-released formulations can be prepared with antibodies mixed with HA, optionally with other polymers.
AbstractList The present disclosure provides compositions and methods for extended release of certain types of antibodies in vivo. It was discovered that such antibodies are able to initiate reversible gelation of hyaluronic acid (HA) by creating a depot that dissociates over time to release the antibody without any impact on its physical and chemical properties as well as its biological activity. As certain tissues and organs, such as eyes, joints and skins, contain HA, local injection of the antibodies to these tissues or organs will result in embedding of the antibody in gel formed from the HA, which becomes a repository of slow-released antibodies. In addition, slow-released formulations can be prepared with antibodies mixed with HA, optionally with other polymers.
Author HSU, Chung-Chiang
ALANI, Laman
Author_xml – fullname: HSU, Chung-Chiang
– fullname: ALANI, Laman
BookMark eNrjYmDJy89L5WRQcY0IcfVzcXVR8PF3dvRRCHL1cXUMdlXwd1Nw9AvxdPJ38XQN5mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BJkbmhiaGRo6GxkQoAQD_YSQP
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate VERLÄNGERTE LOKALE FREISETZUNG VON ANTIKÖRPERN
LIBÉRATION LOCALE ÉTENDUE D'ANTICORPS
ExternalDocumentID EP4271412A1
GroupedDBID EVB
ID FETCH-epo_espacenet_EP4271412A13
IEDL.DBID EVB
IngestDate Fri Nov 08 04:41:50 EST 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP4271412A13
Notes Application Number: EP20210916306
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231108&DB=EPODOC&CC=EP&NR=4271412A1
ParticipantIDs epo_espacenet_EP4271412A1
PublicationCentury 2000
PublicationDate 20231108
PublicationDateYYYYMMDD 2023-11-08
PublicationDate_xml – month: 11
  year: 2023
  text: 20231108
  day: 08
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies Ammax Bio, Inc
RelatedCompanies_xml – name: Ammax Bio, Inc
Score 3.5001035
Snippet The present disclosure provides compositions and methods for extended release of certain types of antibodies in vivo. It was discovered that such antibodies...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title EXTENDED LOCAL RELEASE OF ANTIBODIES
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231108&DB=EPODOC&locale=&CC=EP&NR=4271412A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NS8MwFH-MKepNp-L8IofR27CZXdceirRNypTallmlt9GkHewyh6v47_sSuulFL-GRwMsH_PLeL8l7ARjYbklLOhZDQW1TheQgpCQS18pFX1tYtSOkfm2R2NNX66kYFx1YbmNhdJ7QL50cERElEe-N3q_XP4dYTL-t3NyJJVa9P0S5x4yWHaOzQk3HYIHHs5SloRGGKBnJzLNGE2rRkY9EaQ-96IkCA38LVFDK-rdFiY5hP0Nlq-YEOvWqB4fh9uO1Hhw8t_fdKLbQ25zCgBc5TxhnJE5DPyYzHnP_hZM0In6SPwapcuzOgEQ8D6dD7G6-m9qcZ7uB3Z9DFxl_fQHENZ2FVdIK6YZKDlMJl-pC1ijISvah_6eay3_aruBIrZEOpXOuodt8fNY3aFMbcatX4xtF1XZQ
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT4MwFH9ZpnHedGqcnz0s3BbpZAwOxEApYcqATDTcCAVMdpmLw_jv-2jY9KKX5qVNXj-SX9_7tX2vAEPdzGlOJ2IkqK42ITkIqQKJa2miry20yhCFfG0R6v6L9phO0g4st7EwMk_ol0yOiIgqEO-13K_XP4dYrnxbubkTS6x6f_ASy1VadozOClUNxXUsHkduxBTGUFLChaWNp1SjYxuJ0h562NMGDPzVaYJS1r8tincE-zEqW9XH0KlWfeix7cdrfTiYt_fdKLbQ25zAkKcJD13ukiBidkAWPOD2MyeRR-wwmTlR49idAvF4wvwRdpftppbxeDew-zPoIuOvzoGYqvGm5bREutEkhymFSWVRVCgUZTGAwZ9qLv5pu4Wen8yDLJiFT5dw2KyXDKszrqBbf3xW12hfa3EjV-Yb_OB5Qw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=EXTENDED+LOCAL+RELEASE+OF+ANTIBODIES&rft.inventor=HSU%2C+Chung-Chiang&rft.inventor=ALANI%2C+Laman&rft.date=2023-11-08&rft.externalDBID=A1&rft.externalDocID=EP4271412A1